The 6p deletion syndrome: a new orofacial clefting syndrome and its implications for antenatal screening

A Topping1, P Harris, A L H Moss

  • 1Department of Plastic and Reconstructive Surgery, St George's Hospital, London, UK.

Insights

Foetal genetic screening raises ethical concerns regarding eugenics and potential misuse. This case report details 6p deletion syndrome, an orofacial clefting condition, and discusses UK foetal screening policies.

Area of Science:

  • Medical Genetics
  • Bioethics
  • Reproductive Medicine

Background:

  • Foetal genetic screening is ethically debated, focusing on screening for chromosomal defects.
  • Concerns exist about using genetic screening for eugenics or to select for specific traits.
  • The medical establishment faces challenges in managing genetic screening policies.

Purpose of the Study:

  • To highlight ethical issues in foetal genetic screening.
  • To present a case report of 6p deletion syndrome, an orofacial clefting condition.
  • To discuss the implications of genetic testing policies for individuals and medical units.

Main Methods:

  • Case report detailing a patient with a genetic abnormality.
  • Description of the 6p deletion syndrome.
  • Methodology for detecting chromosomal aberrations.
  • Comparison with existing literature on 6p deletion syndrome.

Main Results:

  • Evidence suggests 6p deletion syndrome is an orofacial clefting syndrome.
  • The case report provides a detailed description of the syndrome and its detection.
  • Potential for abuse of genetic testing policies by parents and corporations is identified.

Conclusions:

  • Foetal genetic screening requires careful ethical consideration due to potential for eugenics.
  • 6p deletion syndrome is increasingly recognized as an orofacial clefting condition.
  • Current UK foetal screening policies warrant review in light of ethical and practical implications.

Related Concept Videos

Meiosis I01:49

Meiosis I

Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by a...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Nondisjunction01:29

Nondisjunction

During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...